Financial Architects (New Jersey)’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
$255K Hold
2,700
0.04% 286
2023
Q1
$223K Sell
2,700
-193
-7% -$16K 0.04% 299
2022
Q4
$216K Buy
2,893
+141
+5% +$10.5K 0.04% 309
2022
Q3
$227K Buy
+2,752
New +$227K 0.04% 284
2022
Q2
Sell
-2,700
Closed -$318K 94
2022
Q1
$318K Sell
2,700
-100
-4% -$11.8K 0.05% 258
2021
Q4
$363K Buy
2,800
+100
+4% +$13K 0.05% 244
2021
Q3
$306K Hold
2,700
0.04% 260
2021
Q2
$280K Hold
2,700
0.04% 282
2021
Q1
$226K Hold
2,700
0.04% 306
2020
Q4
$246K Hold
2,700
0.05% 254
2020
Q3
$216K Hold
2,700
0.05% 253
2020
Q2
$187K Hold
2,700
0.04% 254
2020
Q1
$170K Hold
2,700
0.05% 235
2019
Q4
$210K Hold
2,700
0.05% 235
2019
Q3
$198K Hold
2,700
0.05% 228
2019
Q2
$166K Hold
2,700
0.03% 260
2019
Q1
$172K Hold
2,700
0.03% 308
2018
Q4
$138K Sell
2,700
-300
-10% -$15.3K 0.03% 313
2018
Q3
$174K Buy
3,000
+300
+11% +$17.4K 0.03% 303
2018
Q2
$131K Hold
2,700
0.02% 353
2018
Q1
$126K Sell
2,700
-2,559
-49% -$119K 0.02% 361
2017
Q4
$198K Buy
5,259
+420
+9% +$15.8K 0.03% 296
2017
Q3
$176K Buy
4,839
+15
+0.3% +$546 0.03% 328
2017
Q2
$190K Buy
4,824
+9
+0.2% +$354 0.03% 297
2017
Q1
$151K Sell
4,815
-2,601
-35% -$81.6K 0.03% 332
2016
Q4
$232K Sell
7,416
-1,044
-12% -$32.7K 0.05% 226
2016
Q3
$340K Buy
8,460
+3,369
+66% +$135K 0.09% 175
2016
Q2
$169K Buy
5,091
+1,425
+39% +$47.3K 0.05% 274
2016
Q1
$108K Buy
+3,666
New +$108K 0.04% 259
2015
Q3
Sell
-3,636
Closed -$86K 429
2015
Q2
$86K Sell
3,636
-600
-14% -$14.2K 0.03% 323
2015
Q1
$101K Sell
4,236
-564
-12% -$13.4K 0.04% 284
2014
Q4
$102K Sell
4,800
-600
-11% -$12.8K 0.04% 244
2014
Q3
$92K Sell
5,400
-1,200
-18% -$20.4K 0.05% 233
2014
Q2
$94K Buy
+6,600
New +$94K 0.05% 235